Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5935 USD | +0.15% | -1.05% | +11.98% |
04-16 | BioNexus Gene Lab Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-29 | BioNexus Gene Lab Corp. Provides Information to Shareholders | CI |
Sales 2022 | 10.93M 875M | Sales 2023 | 9.77M 782M | Capitalization | 9.36M 750M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | -2M -160M | EV / Sales 2022 | 14.9 x |
Net cash position 2022 | 2.06M 165M | Net cash position 2023 | 5.78M 463M | EV / Sales 2023 | 0.37 x |
P/E ratio 2022 |
-461
x | P/E ratio 2023 |
-3.2
x | Employees | 30 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 35.63% |
1 day | +0.15% | ||
1 week | -1.05% | ||
Current month | -15.93% | ||
1 month | -15.21% | ||
3 months | +11.98% | ||
6 months | +45.75% | ||
Current year | +11.98% |
Managers | Title | Age | Since |
---|---|---|---|
Lee Su-Leng Tan
CEO | Chief Executive Officer | 40 | 31/07/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chee Keong Yap
BRD | Director/Board Member | 68 | 06/03/22 |
Wei Foong Lim
BRD | Director/Board Member | 48 | 12-10 |
Lee Su-Leng Tan
CEO | Chief Executive Officer | 40 | 31/07/23 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.5935 | +0.15% | 37,932 |
25/04/24 | 0.5926 | -0.40% | 44,884 |
24/04/24 | 0.595 | +2.23% | 56,993 |
23/04/24 | 0.582 | -6.13% | 156,866 |
22/04/24 | 0.62 | +3.37% | 295,592 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+11.98% | 10.49M | |
-17.89% | 8.25B | |
+39.20% | 3.58B | |
-39.11% | 2.46B | |
-8.06% | 2.46B | |
-7.35% | 2.38B | |
-19.01% | 1.55B | |
-40.66% | 1.21B | |
+7.56% | 1.11B | |
-15.34% | 1.03B |
- Stock Market
- Equities
- BGLC Stock